NASP 2021 Accepted Posters: Collection #5
Poster #33: Clinical Intervention Impact in Cystic Fibrosis
Poster #34: Droxidopa Persistence and Pharmacist Interventions
Poster #35: PARPi Therapy: Patient Characteristics and Access
Poster #36: Impact of a Specialty Pharmacy Program on Diabetes
Poster #37: Impact of Pharmacist-Liaison Teams on Outcomes
Poster #38: Pharmacist Clinical Decision Support System Alerts
Poster #39: Concomitant Use of Apalutamide and Anticoagulants
Poster #40: Enabling Access to Federal COVID Pharmacy Programs
NASP Members Redeem Credit Here
This is a featured CE activity on the NASP Education Center website, the educational hub of the National Association of Specialty Pharmacy (NASP).
The target audience for this activity is pharmacists and pharmacy technicians. Upon completion of this activity, participants will be able to:
-Describe current trends in the management of specialty outcomes
-Identify operational efficiencies that can impact their daily activities
-Discuss delivery of novel specialty pharmacy services
Brittney Lager, PharmD, FMNM, ABAAHP, CSP
Clinical Account Executive
Vanderbilt Specialty Pharmacy
Brooke Looney, Pharm D, CSP
Vanderbilt Specialty Pharmacy / Vanderbilt University Medical Center
Advance Team Liaison
Clinical Outcomes Manager
SCL Health – Lutheran Medical Center, Wheat Ridge, CO, USA
Stacey Ness, Pharm.D, RPh, CSP, IgCP, MSCS, AAHIVP
Vice President, Clinical Services
Managed Health Care Associates (MHA)
It is the policy of ProCE, LLC to ensure balance, independence, objectivity, and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture, or market products discussed during their presentation. Brittney Lager, Sabrina Livezey, Nicholas McDonald, Sarah Mehaffey, Jessica Mourani,, and Stacey Ness have no relevant financial and/or commercial relationships to disclose.
Brooke Looney has participated in investigator-initiated funded studies through Pfizer and AstraZeneca.
Karen Nenno is an employee of Karyopharma.
Release Date: 9-24-2021
Expiration Date: 9-24-2022
This CE activity is jointly provided by ProCE, LLC and NASP. ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-21-261-H04-P/T has been assigned to this knowledge-based home-study CE activity. This activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Completion of the evaluation and the post-test with a score of 70% or higher are required to receive CE credit. No partial credit will be given.